Physician profile
Thane Htun
NPI 1265482962
$2,002.54
in general payments reported to CMS, 2019-2025
11 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $394 · 2021: $193 · 2022: $67.97 · 2023: $59.52 · 2024: $416 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $669.06 | 2019-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $484.72 | 2021-2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $196.09 | 2021-2024 | Fasenra |
| Glaxosmithkline, LLC. | $125.00 | 2020 | |
| Grifols USA, LLC | $120.94 | 2024 | Xembify |
| Mallinckrodt Enterprises LLC | $114.28 | 2019 | |
| Becton, Dickinson and Company | $91.72 | 2025 | Hemosphere |
| Mylan Specialty L.P. | $86.47 | 2024 | Yupelri |
| Genentech USA, INC. | $80.33 | 2019 | |
| Inspire Medical Systems, INC. | $17.69 | 2024 | Inspire |
| Insmed, INC. | $16.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thane Htun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.